Implant failure · Adults with missing teeth who received osseointegrated root-formed oral implants, functionally loaded and followed for at least 1 year
ITI SLActive titanium grade 4 implants showed no clear difference in implant failure compared with ITI SLActive titanium-13zirconium (Roxolid) implants; GRADE not reported.
1 finding from 1 review
All‐cause mortality ‐ not reported · patients with oesophageal cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
TCM symptoms ‐ ineffectiveness · patients with oesophageal cancer
It is very uncertain whether active cancer therapy combined with TCM changes TCM symptoms ‐ ineffectiveness compared with active cancer therapy (very low certainty).
1 finding from 1 review
Adverse events ‐ mucositis Diagnosed by clinicians · patients with oesophageal cancer
Active cancer therapy combined with TCM showed no clear difference in adverse events ‐ mucositis Diagnosed by clinicians compared with active cancer therapy (low certainty).
1 finding from 1 review
Adverse events ‐ radiation oesophagitis · patients with oesophageal cancer
Active cancer therapy combined with TCM may leads to lower adverse events ‐ radiation oesophagitis compared with active cancer therapy (low certainty).
1 finding from 1 review
Adverse events ‐ arrest of bone marrow · patients with oesophageal cancer
Active cancer therapy combined with TCM probably leads to lower adverse events ‐ arrest of bone marrow compared with active cancer therapy (moderate certainty).
1 finding from 1 review
Adverse events ‐ gastrointestinal reactions Diagnosed by clinicians · patients with oesophageal cancer
It is very uncertain whether active cancer therapy combined with TCM changes adverse events ‐ gastrointestinal reactions Diagnosed by clinicians compared with active cancer therapy (very low certainty).
1 finding from 1 review
Adverse events ‐ renal and hepatic impairment ‐ Fuzheng Guben granules · patients with oesophageal cancer
Active cancer therapy combined with TCM may leads to lower adverse events ‐ renal and hepatic impairment ‐ Fuzheng Guben granules compared with active cancer therapy (low certainty).
1 finding from 1 review
Adverse events ‐ renal and hepatic impairment‐ Xiaoaiping Diagnosed by clinicians · patients with oesophageal cancer
Active cancer therapy combined with TCM showed no clear difference in adverse events ‐ renal and hepatic impairment‐ Xiaoaiping Diagnosed… compared with active cancer therapy (low certainty).
1 finding from 1 review
Adverse events ‐ white blood cell descent Diagnosed by clinicians · patients with oesophageal cancer
It is very uncertain whether active cancer therapy combined with TCM changes adverse events ‐ white blood cell descent Diagnosed by clinicians compared with active cancer therapy (very low certainty).
1 finding from 1 review
Adverse events ‐ neurotoxicity Diagnosed by clinicians · patients with oesophageal cancer
Active cancer therapy combined with TCM showed no clear difference in adverse events ‐ neurotoxicity Diagnosed by clinicians compared with active cancer therapy (low certainty).
1 finding from 1 review
Adverse events ‐ cardiac toxicity Diagnosed by clinicians · patients with oesophageal cancer
Active cancer therapy combined with TCM showed no clear difference in adverse events ‐ cardiac toxicity Diagnosed by clinicians compared with active cancer therapy (low certainty).
1 finding from 1 review
Median survival times ‐ not reported · patients with oesophageal cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to progression · patients with oesophageal cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life ‐ number experiencing improvement · patients with oesophageal cancer
Active cancer therapy combined with TCM may leads to higher quality of life ‐ number experiencing improvement compared with active cancer therapy (low certainty).
1 finding from 1 review
Quality of life ‐ number experiencing deterioration · patients with oesophageal cancer
Active cancer therapy combined with TCM may leads to lower quality of life ‐ number experiencing deterioration compared with active cancer therapy (low certainty).
1 finding from 1 review
Quality of life ‐ Karnofsky performance status Karnofsky status judged by clinicians. Scale: 0 to 100 · patients with oesophageal cancer
1 finding from 1 review
Complete or partial remission · patients with oesophageal cancer
Active cancer therapy combined with TCM probably leads to higher short‐term therapeutic effects ‐ improvement (complete response +… compared with active cancer therapy (moderate certainty).
1 finding from 1 review
Short‐term therapeutic effects ‐ progressive disease · patients with oesophageal cancer
Active cancer therapy combined with TCM showed no clear difference in short‐term therapeutic effects ‐ progressive disease compared with active cancer therapy (low certainty).
1 finding from 1 review
TCM symptoms ‐ total effectiveness · patients with oesophageal cancer
It is very uncertain whether active cancer therapy combined with TCM changes TCM symptoms ‐ total effectiveness compared with active cancer therapy (very low certainty).
1 finding from 1 review